8-53814697-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_015941.4(ATP6V1H):c.490T>A(p.Tyr164Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,611,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_015941.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6V1H | NM_015941.4 | c.490T>A | p.Tyr164Asn | missense_variant | 6/14 | ENST00000359530.7 | NP_057025.2 | |
ATP6V1H | NM_213620.3 | c.490T>A | p.Tyr164Asn | missense_variant | 6/14 | NP_998785.1 | ||
ATP6V1H | NM_213619.3 | c.490T>A | p.Tyr164Asn | missense_variant | 6/13 | NP_998784.1 | ||
ATP6V1H | XM_006716455.4 | c.490T>A | p.Tyr164Asn | missense_variant | 6/13 | XP_006716518.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249278Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134696
GnomAD4 exome AF: 0.00000754 AC: 11AN: 1459728Hom.: 0 Cov.: 29 AF XY: 0.00000413 AC XY: 3AN XY: 726102
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2024 | The c.490T>A (p.Y164N) alteration is located in exon 6 (coding exon 5) of the ATP6V1H gene. This alteration results from a T to A substitution at nucleotide position 490, causing the tyrosine (Y) at amino acid position 164 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at